China Universal Asset Management Co., Ltd.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1906594 SHANGHAI, F4

Position in ENTA

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$67,476

+$2,432 QoQ

Shares Held

4,628

-10.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. ENTA ranks #186 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$67,476	4,628	-10.1%	Shares	Sole	2026-07-24
2026-03-31	$65,044	5,150	+9.5%	Shares	Sole	2026-04-28
2025-12-31	$74,166	4,703	-46.2%	Shares	Sole	2026-01-29
2025-09-30	$104,701	8,747	+103.8%	Shares	Sole	2025-11-10
2025-06-30	$32,455	4,293	+0.3%	Shares	Sole	2025-08-28
2025-03-31	$23,620	4,279	-4.8%	Shares	Sole	2025-04-30
2024-12-31	$25,840	4,494	+720.1%	Shares	Sole	2025-01-24
2023-09-30	$6,121	548	+98.6%	Shares	Sole	2024-05-22
2023-06-30	$5,906	276	-2.5%	Shares	Sole	2024-05-22
2023-03-31	$11,444	283	+34.1%	Shares	Sole	2024-05-22
2022-12-31	$9,815	211	+8.8%	Shares	Sole	2024-05-22
2022-09-30	$10,062	194	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.